MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 26.03.2026
Orgenesis EV 2011-2026 | ORGS
EV Jährlich Orgenesis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38.8 M | 36.1 M | 63.7 M | 92.2 M | 124 M | 167 M | 91.9 M | 78 M | 53.7 M | 58.9 M | 29.9 M | 34.4 M | 35.6 M | 956 K |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 167 M | 956 K | 64.6 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
4.15 M | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
6.3 M | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
3.93 M | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
168 B | - | 2.54 % | $ 160 B | France |
 |
AstraZeneca PLC
AZN
|
59.6 B | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-4.92 M | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
686 M | - | 0.74 % | $ 768 M |  Israel |
 |
Galera Therapeutics
GRTX
|
-5.73 M | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
-1.76 M | - | -18.52 % | $ 27.3 M | Britain |
 |
Esperion Therapeutics
ESPR
|
1.16 B | $ 3.14 | 0.32 % | $ 653 M | USA |
 |
Eton Pharmaceuticals
ETON
|
599 M | $ 35.52 | 3.11 % | $ 956 M | USA |
|
Forte Biosciences
FBRX
|
280 M | $ 21.7 | 6.84 % | $ 281 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
11.4 M | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
-1.83 M | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | USA |
 |
Generation Bio Co.
GBIO
|
68.7 M | - | - | $ 344 M | USA |
 |
IMV
IMV
|
23.6 M | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | USA |
 |
BioNTech SE
BNTX
|
17.1 B | $ 91.61 | 1.38 % | $ 22.1 B | Germany |
 |
Grifols, S.A.
GRFS
|
16.3 B | $ 8.15 | -0.55 % | $ 5.54 B |  Spain |
 |
Autolus Therapeutics plc
AUTL
|
629 M | $ 1.67 | 3.09 % | $ 444 M | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | Israel |
 |
Heron Therapeutics
HRTX
|
411 M | $ 0.88 | 3.99 % | $ 147 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-2.16 M | - | -4.36 % | $ 27 M | USA |
 |
Compugen Ltd.
CGEN
|
106 M | $ 2.66 | -1.85 % | $ 249 M | Israel |
 |
Anika Therapeutics
ANIK
|
156 M | $ 15.15 | 0.07 % | $ 217 M | USA |
 |
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
10.3 M | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
4.35 M | - | - | $ 26.5 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-721 K | $ 3.41 | 2.71 % | $ 5.61 M | Israel |
 |
AIkido Pharma
AIKI
|
9.53 M | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | USA |
 |
Coherus BioSciences
CHRS
|
335 M | $ 1.59 | 5.43 % | $ 186 M | USA |
 |
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
-55.1 M | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
31 K | - | - | $ 28.6 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 20.95 | 2.34 % | $ 2.67 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-14.1 M | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | USA |